Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332904
Status:
UNKNOWN
Last Update Posted:
2010-06-04
First Post:
2006-05-31
Brief Title:
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
Sponsor:
Hvidovre University Hospital
Organization:
Hvidovre University Hospital
Study Overview
Official Title:
Effect of Betablocker or Aldosterone Antagonist Therapy on Oxygenation Peripheral and Cardiac Hemodynamics and Humoral Systems
Status:
UNKNOWN
Status Verified Date:
2010-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PEKASYS
Brief Summary:
The studys purpose is to investigate the effect of beta blockade or aldosterone antagonist therapy on oxygenation peripheral and cardiac hemodynamics and humoral systems in patients with liver cirrhosis
Detailed Description:
Cardio-pulmonal complications to patients with liver cirrhosis and portal hypertension determine the patients prognosis Most patients have hemodynamical changes in circulation with increased cardiac output and decreased systolic function in stress Endothelial dysfunction is a parameter for bad prognosis in cardiovascular disease The Renin-angiotensin-aldosterone-system plays an important role in natrium and volume regulation Descriptions of changes in the peripheral circulation and oxygenation have been deficient up to now
Patients with liver cirrhosis and portal hypertension are betablockers andor aldosterone antagonists routine treatment - effects on peripheral hemodynamics and oxygenation in relation to central hemodynamic changes are deficient
Patients with liver cirrhosis and portal hypertension are betablockers andor aldosterone antagonists routine treatment - effects on peripheral hemodynamics and oxygenation in relation to central hemodynamic changes are deficient
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None